@opzelura_ruxolitinib: Tap @opzelura_ruxolitinib_pi for Full PI, including Box Warning, Med Guide. See if OPZELURA may be a good fit on a repigmentation journey. INDICATION & USAGE OPZELURA is a prescription medicine used on the skin (topical) for the treatment of a type of vitiligo called nonsegmental vitiligo in adults and children 12 years of age and older The use of OPZELURA along with therapeutic biologics, other JAK inhibitors, or strong immunosuppressants such as azathioprine or cyclosporine is not recommended. SELECT SAFETY INFORMATION OPZELURA may cause serious side effects. OPZELURA is in a class of medicines called Janus kinase (JAK) inhibitors, which can lower ability to fight infections. Serious infections, some fatal, occurred when taking JAK inhibitors by mouth including tuberculosis and infections caused by bacteria, fungi, or viruses. Some serious lung infections were seen in people using OPZELURA. Before starting OPZELURA, tell your provider if you have: an infection, diabetes, lung disease, HIV, or a weak immune system. Increased risk of death in people age 50+ with at least one heart disease risk factor when taking JAK inhibitors by mouth. OPZELURA may increase your risk of certain cancers by changing the way your immune system works. People taking JAK inhibitors by mouth have higher risk of certain cancers. Some people had skin cancers while using OPZELURA. Tell your doctor if you have had any type of cancer. Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least one heart disease risk factor when taking JAK inhibitors by mouth, especially in current or past smokers. Blood clots in veins of your legs (deep vein thrombosis) or lungs (pulmonary embolism) can happen. This may be life-threatening. These types of blood clots occurred more often in people 50+ with at least one heart disease risk factor when taking JAK inhibitors by mouth.

OPZELURA® (ruxolitinib)

Open In TikTok:

Region: US

Friday 11 September 2026 23:09:46 GMT